Systemic sclerosis and infections

Autoimmunity Reviews

Volumn 8, Issue 1, 2008, Pages 36-40

  Randone, Silvia Bellando ^a   Guiducci, Serena ^a   Cerinic, Marco Matucci ^a  

^a Division of Rheumatology AOUC   (Italy)

Author keywords

Cytomegalovirus; Infections; Parvovirus B19; SSc pathogenesis; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; SUPERANTIGEN;

ANTIBODY RESPONSE; BACTERIAL INFECTION; BLOOD VESSEL OCCLUSION; CELL DAMAGE; CONNECTIVE TISSUE DISEASE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; EPSTEIN BARR VIRUS; EXTRACELLULAR MATRIX; GASTROINTESTINAL DISEASE; HEART MUSCLE FIBROSIS; HELICOBACTER PYLORI; HUMAN; KIDNEY FIBROSIS; LUNG FIBROSIS; MICROCHIMERISM; MICROENVIRONMENT; MOLECULAR MIMICRY; NONHUMAN; PARVOVIRUS; PATHOGENESIS; RETROVIRUS; REVIEW; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; VIRUS INFECTION;

ANTIGENS, BACTERIAL; ANTIGENS, VIRAL; CHIMERISM; ENDOTHELIAL CELLS; FIBROSIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNITY, INNATE; MOLECULAR MIMICRY; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; SCLERODERMA, SYSTEMIC; SUPERANTIGENS;

EID: 54549122563     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.022     Document Type: Review

References (42)

1. Le Roy E.C., Black C., Fleischmajer, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15 (1988) 202-205
2. Mouthon L., Garcia de la Pena-Lefebvre P., Chanseaud Y., Tamby M.C., Boissier M.C., et al. Pathogenesis of systemic scleroderma: immunological aspects. Ann Med Interne (Paris) 153 (2002) 167-178
3. White B. Immunopathogenesis of systemic sclerosis. Rheum Dis Clin North Am 22 (1996) 695-708
4. LeRoy E.C. Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 22 675 (1996) 694
5. Vaughan J.H., Shaw P.X., Nguyen M.D., Medsger T.J., Wright T.A., Metcalf J.S., et al. Evidence of activation of 2 herpesvirus, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. J Rheumatol 27 (2000) 821-823
6. Ferri C., Giuggioli D., Sebastian M., Zakrzewaka K., Azzi A., Panfilo S., et al. Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients. Arthritis Rheum 46 (2002) 2262-2263
7. Ferri C., Zakrzewaka K., Longombardo G., et al. Parvovirus B19 infection of bone narrow in systemic sclerosis patients. Clin Exp Rheumat 17 (1999) 718
8. Ferri C., Cazzato M., Giuggioli D., Sebastiani M., and Magro C.M. Systemic sclerosis following human cytomegalovirus infection. Ann Rheum Dis 61 (2002) 937-938
9. Ferri C., Zakrzewaka K., and Giuggioli D. Parvovirus B19 infection in the skin and bone narrow in systemic sclerosis patients. Arthritis Rheum 42 (2008) 1491
10. Nikkari S., Mertsola J., and Korvenranta H. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum 37 (1994) 1707
11. Finkel T.H., Torok T.J., Ferguson P.J., et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent. Lancet 343 (1994) 1255
12. Veraldi S., Mancuso R., Rizzitelli G., et al. Henoch Schonlein syndrome associated with human parvovirus B19 infection. Eur J Dermatol 9 (1999) 232
13. Crowson A.N., Magro C.M., and Dawood M.R. A casual role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol 27 (2000) 505
14. Ferri C., Longombardo G., Azzi A., and Zakrzewaka K. Parvovirus B19 and systemic sclerosis. Clin Exp Rheumat 17 (1999) 267
15. Yoto Y., Kudoh T., Haseyama K., Suzuki N., Oda T., Katoh T., et al. Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 91 (1995) 1017-1018
16. Cassinotti P., Burtonoboy G., Fopp M., and Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone narrow. J Med Virol 53 (1997) 229-232
17. Magro C.M., Nuovo G.J., Ferri C., Crowson A.N., Giuggioli D., and Sebastiani M. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol 31 (2004) 43-50
18. Sol N., Le Junter J., and Vassias I. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 73 (1999) 8762
19. Ferri C., Giuggioli D., Sebastian M., Zakrzewaka K., Azzi A., Panfilo S., et al. Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients. Arthritis Rheum 49 (2000) 1491
20. Ray N.B., Nieva D.R.C., Seftor E.A., et al. Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts. Arthritis Rheum 44 (2001) 1582-1586
21. Pandey P., and LeRoy E.C. Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum 41 (1998) 10-15
22. Zhou Y.F., Show M., Harrell R.F., Yu Z.X., Unger E.F., and Epstein S.E. Chronic non vascular cytomegalovirus infection: effects on the neointimal response to experimental vascular injury. Cardiovasc Res 45 4 (2000) 1019-1025
23. Shahgasempour S., Woodroffe S.B., Sullivan-Tailyour G., and Garnet H.M. Alteration in the expression of endothelial cell integrin receptors alpha5beta1 and alpha2beta1 and alpha6beta1 after in vitro infection with a clinical isolate of human cytomegalovirus. Arch Virol 142 (1997) 125-138
24. Vaughan J.H., Smith E.A., LeRoy E.C., Arnett F.C., Wright T.A., and Medsger T.J. An autoantibody in systemic scleroderma that reacts with glycine rich sequences. Arthritis Rheum 38 Suppl 9 (1995) 255
25. Muryoi T., Kasturi K.N., Kafina M.J., Cram D.S., Harrison L.S., Sasaki T., et al. Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes. J Exp Med 175 (1992) 1103-1109
26. Muryoi T., Kasturi K.N., Kafina M.J., Saitoh Y., Usuba O., Perlish J.S., et al. Self reactive repertoire of tight skin mouse: immunochemical and molecular characterization of anti-topoisomerase I autoantibodies. Autoimmunity 9 2 (1991) 109-117
27. Tsukamoto K., Hayakawa H., Sato A., Chida K., Nakamura H., and Miura K. Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 55 (2000) 958-961
28. Rhodes G.H., Valbrach J.R., Nguyen M.D., and Vaughan J.H. The p452 gene encodes an autoantigen that cross reacts with EBNA-1 of the Epstein-Barr virus and which may be a heterogeneous nuclear ribonucleoprotein. J Autoimmun 10 (1997) 447-454
29. Query C.C., and Keene J.D. A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 51 (1987) 211-220
30. Banki K., Maceda J., Hurley E., Ablonczy E., Mattson D.H., Szegedy L., et al. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-1-gag-reactive autoantibodies. Proc Natl Acad Sci USA 89 (1992) 1939-1943
31. Maul G.G., Jimenez S.A., Riggs E., and Zeimnicka-Kotula D. Determination of an epitope of the diffuse scleroderma marker antigen topoisomerase I. Sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in scleroderma. Proc Natl Acad Sci 86 (1989) 8492-8496
32. Dang H., Dauphinée M.J., and Talal N. Serum antibody to retroviral gag proteins in systemic sclerosis. Arthritis Rheum 34 (1991) 1336-1337
33. Kalabay L., Fekete B., Czirjàk L., Horvàth L., Daha M.R., Veres A., et al. Helicobacter pylori infection in connective tissue disorders is associated with levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 7 (2002) 250-258
34. Mendall M.A., Goggin P.M., Molineaux N., Levy J., Toosy T., Strachan D., et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71 (1994) 437-439
35. Gasbarrini A., et al. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci 43 (1998) 1641-1645
36. Macchia G., Massone A., Burroni D., Covacci A., Censini S., and Rappuoli R. The hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastrointestinal diseases. Mol Microbiol 3 (1993) 645-652
37. Tachibana I., Bodorova J., Berditchevski F., Zutter M.M., and Helmer M.E. NAG-2 a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. J Biol Chem 272 (1997) 29181-29189
38. Ferri C., Valentini G., Cozzi F., et al. Systemic sclerosis: demographic, clinical and serological features and survival in 1012 Italian patients. Medicine 81 (2002) 139
39. Bordron A., Dueymes M., Levy Y., Jamin C., Leroy J.P., Piette J.C., et al. The binding of some human antiendothelial cell antibodies induce endothelial cell apoptosis. J Clin Invest 101 (1998) 2029-2035
40. Hamamdzic D.V.M., Kasman L.M., and LeRoy E.C. Role of infectious agents in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 14 (2002) 694-698
41. Lobo-Yeo A., and Lamb J.R. Superantigens as immunogens and tolerogens. Clin Exp Rheumatol 11 (1993) 17-21
42. Giacomelli R., Cipriani P., Fulminis A., Nelson L., and Matucci Cerinic M. Gamma/delta T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosis. Clin Exp Rheumatol 22 (2004) 28-30